Dujuan Liu , Sandra Garrigues , Helena Culleton , Vincent A. McKie , Ronald P. de Vries
{"title":"Analysis of the molecular basis for the non-amylolytic and non-proteolytic nature of Aspergillus vadensis CBS 113365","authors":"Dujuan Liu , Sandra Garrigues , Helena Culleton , Vincent A. McKie , Ronald P. de Vries","doi":"10.1016/j.nbt.2024.04.003","DOIUrl":null,"url":null,"abstract":"<div><p><em>Aspergillus vadensis</em> CBS 113365, a close relative of <em>A. niger</em>, has been suggested as a more favourable alternative for recombinant protein production as it does not acidify the culture medium and produces very low levels of extracellular proteases. The aim of this study was to investigate the underlying cause of the non-amylolytic and non-proteolytic phenotype of <em>A. vadensis</em> CBS 113365. Our results demonstrate that the non-functionality of the amylolytic transcription factor AmyR in <em>A. vadensis</em> CBS 113365 is primarily attributed to the lack of functionality of its gene’s promoter sequence. In contrast, a different mechanism is likely causing the lack of PrtT activity, which is the main transcriptional regulator of protease production. The findings presented here not only expand our understanding of the genetic basis behind the distinct characteristics of <em>A. vadensis</em> CBS 113365, but also underscore its potential as a favourable alternative for recombinant protein production.</p></div>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":"82 ","pages":"Pages 25-32"},"PeriodicalIF":4.5000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1871678424000141/pdfft?md5=5eda25cb7805f55b9da5e9cc3e40155a&pid=1-s2.0-S1871678424000141-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871678424000141","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Aspergillus vadensis CBS 113365, a close relative of A. niger, has been suggested as a more favourable alternative for recombinant protein production as it does not acidify the culture medium and produces very low levels of extracellular proteases. The aim of this study was to investigate the underlying cause of the non-amylolytic and non-proteolytic phenotype of A. vadensis CBS 113365. Our results demonstrate that the non-functionality of the amylolytic transcription factor AmyR in A. vadensis CBS 113365 is primarily attributed to the lack of functionality of its gene’s promoter sequence. In contrast, a different mechanism is likely causing the lack of PrtT activity, which is the main transcriptional regulator of protease production. The findings presented here not only expand our understanding of the genetic basis behind the distinct characteristics of A. vadensis CBS 113365, but also underscore its potential as a favourable alternative for recombinant protein production.
黑曲霉(A. niger)的近亲瓦登曲霉(Aspergillus vadensis)CBS 113365 不酸化培养基,产生的胞外蛋白酶水平很低,因此被认为是重组蛋白生产的更有利替代品。本研究的目的是调查 A. vadensis CBS 113365 的非乳化和非蛋白水解表型的根本原因。我们的研究结果表明,A. vadensis CBS 113365 中的淀粉溶解转录因子 AmyR 的无功能性主要归因于其基因启动子序列缺乏功能性。相比之下,导致蛋白酶生产的主要转录调节因子 PrtT 缺乏活性的可能是另一种机制。本文介绍的研究结果不仅拓展了我们对 A. vadensis CBS 113365 独特特征背后遗传基础的理解,还强调了其作为重组蛋白生产的有利替代品的潜力。
期刊介绍:
New Biotechnology is the official journal of the European Federation of Biotechnology (EFB) and is published bimonthly. It covers both the science of biotechnology and its surrounding political, business and financial milieu. The journal publishes peer-reviewed basic research papers, authoritative reviews, feature articles and opinions in all areas of biotechnology. It reflects the full diversity of current biotechnology science, particularly those advances in research and practice that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion and comment on broader issues of general interest and concern. The outlook is fully international.
The scope of the journal includes the research, industrial and commercial aspects of biotechnology, in areas such as: Healthcare and Pharmaceuticals; Food and Agriculture; Biofuels; Genetic Engineering and Molecular Biology; Genomics and Synthetic Biology; Nanotechnology; Environment and Biodiversity; Biocatalysis; Bioremediation; Process engineering.